《亞洲股市》日經倒跌近0.8% 菲台股續升0.6%-0.7% 中港股市反覆向好
美國10月諮商會就業趨勢指數創至少兩年高,加上美國周一起放寬33國已接種新冠疫苗的旅客入境免隔離限制,眾議院通過逾萬億美元基建方案,市場憧憬經濟加快復甦,美股昨晚全面繼續反覆造好,道指連續兩天創紀錄高。然而,美股期貨全面回吐不足0.2%。
亞太區股市個別發展。美元兌日圓續跌0.4%至112.75,日經三連跌兼低收,最高見29,750,收29,285,倒跌221點或近0.8%。澳股、新加坡、印度及馬來西亞股市跌0.2%-0.9%,後者最傷報1,522,孟買指數扭兩連升,最高見60,670,現報60,381,反覆回吐0.3%。
相反,台灣加權指數續升0.7%報17,541創逾三個月高;已連日跑贏的菲股四連升,報7,441,升0.6%。越南、泰國、印尼及新西蘭股市升不足0.4%,前者四連升。韓股連跌兩天後,今天反覆回穩報2,960。
上證及深成報3,507及14,563,反覆續升約0.3%。港股在藥明生物(02269.HK)急彈逾9.5%及餘下三隻醫藥股、比亞迪(01211.HK)及吉利(00175.HK)升逾1%-3%支撐反覆回穩,高低見24,956/24,678,現報24,805,反覆回升41點或不足0.2%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.